Cardiol Therapeutics | WebDisclosure

PRESS RELEASE

published on 02/27/2024 at 14:16, 2 years 6 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024

FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years 6 months ago

Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx

FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years 6 months ago

Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx

Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
PRESS RELEASE

published on 01/19/2024 at 12:41, 2 years 7 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided.

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE

published on 08/30/2023 at 15:06, 3 years ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/24/2023 at 13:01, 3 years 3 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 04/11/2023 at 15:26, 3 years 4 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy

Published on 09/05/2026 at 04:05, 2 days 12 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 16 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 17 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 17 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 3 days 1 hour ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

Published on 09/07/2026 at 15:26, 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/07/2026 at 15:24, 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/07/2026 at 15:23, 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 09/07/2026 at 15:22, 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 09/07/2026 at 15:22, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

View all EQS

Published on 09/07/2026 at 15:03, 1 hour 1 minute ago

voting rights
Published on 09/07/2026 at 15:03, 1 hour 1 minute ago

droits de vote
Published on 09/07/2026 at 08:30, 7 hours 35 minutes ago

Dépôt d’une actualisation du document d’enregistrement universel
Published on 09/07/2026 at 08:25, 7 hours 39 minutes ago

Dépôt d’une actualisation du document d’enregistrement universel
Published on 09/07/2026 at 08:20, 7 hours 44 minutes ago

Derichebourg annonce le lancement d’une offre d’obligations vertes senior

View all LES ECHOS COMFI WIRE

News